Skip to main content
Equibles

Caitong International Asset Management Co., Ltd

Position in LSTA — Lisata Therapeutics, Inc.

CIK 1963355 HONG KONG, K3
Back to LSTA Full portfolio

Position in LSTA

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$306
+$196 QoQ
Shares Held
90
+309.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 31 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LSTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caitong International Asset Management Co., Ltd holds $9,916,071 across 351 Biotechnology names. LSTA ranks #172 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABSI
Absci Corp
 157,319 $1,823,327
2 NTLA
Intellia Therapeutics, Inc.
 46,732 $790,705
3 TECH
BIO-TECHNE Corp
 9,888 $698,587
4 ARGX
Argenx SE
 655 $607,689
5 QURE
uniQure N.V.
 9,644 $444,202
6 BEAM
Beam Therapeutics Inc.
 10,377 $356,138
7 NAMS
NewAmsterdam Pharma Co N.V.
 9,682 $328,122
8 ABCL
AbCellera Biologics Inc.
 41,632 $326,811

All Filings in LSTA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $306 90
2026-03-31 $110 22